Understanding NIH's overall structure and the foundation of the agency's grants process is vital to successfully applying for NIH funding. To help you on this journey, the NIH invites you to participate in a two-part webinar designed to help inform and clarify important elements from application preparation to award.



Due to the popularity of this topic, there is a strong possibility of reaching capacity on Zoom. Therefore, on event day plan on signing in early. Once capacity is reached, you will be redirected to a live stream on YouTube.

Register one time for access to both Part One and Part Two. 

Part One: An Overview (November 13, 2024 / 1:00 - 4:00 P.M. ET)

• Introduction to NIH
• Identifying Funding Opportunities
• Elements of a Competitive Application (key components and guidance from NIH experts)
• Understanding the Peer Review Process
• Award Determination
• Q&A focused on pre-award preparations and the path of your application toward award

NIH experts will be available to address questions submitted during registration to help smooth the path toward a successful NIH application process.

This webinar will be co-hosted by the Office of Extramural Research (OER) and the Center for Scientific Review (CSR).

Audience:

This event is designed for participants new to working with the NIH grants process – investigators, administrators, and others looking to enhance their knowledge of pre-award activities, systems, and resources.

The NIH invites you to participate in a two-part webinar designed to help inform and clarify important elements from application preparation to award.

Due to the popularity of this topic, there is a strong possibility of reaching capacity on Zoom. Therefore, on event day plan on signing in early. Once capacity is reached, you will be redirected to a live stream on YouTube.

Register one time for access to both Part One and Part Two. 

Part Two: An Interactive Experience (November 14, 2024 / 1:00 - 4:00 P.M. ET)

• Pre-Award Systems (Walk-through of systems and tools used to submit and track applications)
• Notices of Funding Opportunities
• Application Components & Guidance (e.g., deadlines, budget types, project narratives, supporting documents, and application assembly)
• Peer Review Outcomes, Responding, and Tips on Resubmitting
• Award Notification and Acceptance (e.g., understanding the Notice of Award)
• Preparing for Managing an Award
• Q&A focused on systems, tools, and resources from submission to award

NIH experts will be available to address questions submitted during registration to help smooth the path toward a successful NIH application process.

This webinar will be co-hosted by the Office of Extramural Research (OER) and the Center for Scientific Review (CSR).

Audience:

This event is designed for participants new to working with the NIH grants process – investigators, administrators, and others looking to enhance their knowledge of pre-award activities, systems, and resources.

Fellowship applications submitted on or after January 25, 2025 will follow a revised application and review criteria. The goal of the changes is to improve the chances that the most promising fellowship candidates will be consistently identified by scientific review panels.

The extramural community is informed this Guide Notice about NIH's adoption of Common Forms for Biographical Sketch and Current and Pending (Other) Support to be used with all applications and Research Performance Progress Report(s) (RPPRs) by May 25, 2025.

For due dates on or after January 25, 2025, FORMS-I application packages should be used by applicants, while FORMS-H application packages should be used for due dates on or before January 24, 2025. If applications are submitted with an incorrect forms package for their intended due date, they will be withdrawn and removed from funding consideration.

Starting October 1, 2024, foreign recipients (either serving as a direct or subrecipient of NIH grants and cooperative agreements) who expend $750,000 (cumulative amount) or more in Federal awards during their fiscal year will be required to conduct either a single audit, performed in accordance with the requirements outlined in 2 CFR 200 Subpart F, or program-specific audit.

On January 25, 2025, the NIH is going to update two practices under the NIH Genomic Data Sharing (GDS) Policy to continue to promote responsible data management and access. The goal of these changes is to make sure that GDS Policy implementation keeps up with the changing practices of collecting, sharing, and using controlled-access human genomic data, which includes - (1) modernizing security standards provided in the “NIH Security Best Practices for Controlled-Access Data Subject to the NIH Genomic Data Sharing (GDS) Policyand (2) establishing minimum expectations for developers' access to controlled-access data.

The NIH Extramural Loan Repayment Program (LRP) application cycle is open from September 1 to November 21 this year. Participants in the NIH LRPs can receive up to $100,000 of qualified educational debt repayment with a two-year award. Please contact lrp@nih.gov for further details. 

To gain a deeper understanding of this exceptional opportunity, attend the LRP Technical Assistance Webinar on October 7, 2024 (click on the link to register). The webinar will contain important information about the LRP application process, eligibility requirements, and the many benefits of receiving an LRP award.

NIDA released a new funding opportunity that is soliciting proposals for research and development activities to create commercially viable products to address the health consequences of non-disordered drug use. The scope of proposed projects may encompass FDA-regulated areas such as pharmacotherapeutics, including small molecules and biologics, or medical therapeutic and diagnostic devices, including software classified as a medical device.

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional) RFA-DA-25-050.

The Glioblastoma Research Program (GBMRP) released program announcements for the following funding opportunities:

·       Resource Development Award (LOI due on November 6, 2024 at 5 PM EST)

·       Hypothesis Development Award (wither Partnering Principal Investigator Option)

[LOI due on November 6, 2024 at 5 PM EST]

The Warren Alpert Distinguished Scholars Program will support individual postdoctoral scientists of exceptional creativity in the field of neurosciences. These transition awards are intended to enable a postdoctoral researcher to advance to become a full-time faculty member at the Assistant Professor or higher level, and to promote the development of a laboratory program that will lead to independent funding. The institution appointing the scholar will be awarded $200,000 annually for two years to cover salary, lab costs, and related expenses. Under certain circumstances, the awardee may transfer funding to support their beginning faculty position. Indirect costs of up to 15% of direct costs may be included in the $200,000.

Eligibility requirements:

• Must have an MD, PhD, or both
• Must hold a postdoctoral research position
• Minimum of 3 years and no more than 6 years of a postdoctoral fellowship by July 1, 2025
• Research focused in the field of Neuroscience
• Must be nominated by the dean of the medical school or equivalent institutional senior leader
• Must include a nomination letter
• Commitment of a minimum of 75% effort
• Three letters of recommendation
• Budgets submitted in G300 format
• Applicants with a Visa are allowed to be nominated with the stipulation that their Visa status must allow them to complete the award here in the United States

All applications must be submitted electronically no later than November 1, 2024. The application link along with submission instructions can be found here.

Award Categories:

Scholar. These 5-year, $120,000/year awards support emerging leaders in the blood cancer research field. You must be a highly qualified, early/mid-career laboratory-based investigator who has an impactful and innovative research program focused on hematologic malignancies and/or relevant premalignant conditions. You must hold an independent, tenure-track, faculty-level position and should have substantial research support from a national agency.

Scholar in Clinical Research. These 5-year, $125,000/year awards support highly qualified clinical investigators who hold an independent faculty-level appointment and are conducting independent applied research that will advance the prevention, diagnosis, and/or treatment of hematologic malignancies and/or relevant premalignant conditions. The research must involve patients and be related to your overall clinical activities. You must have substantial support for your research from another source.

Special Fellow. These 2 or 3 year, $75,000/year awards support highly qualified, mentored postdoctoral fellows and instructors who have 3-5 years of postdoctoral research training (as of the award start date) and are continuing a research program of direct relevance to hematological malignancies and/or relevant premalignant conditions. In addition, your Sponsor must have the appropriate experience to mentor you as you engage in blood cancer research. This award provides you with the opportunity to continue building a research program that will make you competitive for an independent position by the end of the award funding period.

Fellow. These 3-year, $70,000/year awards support top performing, mentored postdoctoral fellows and instructors who are training for a career in hematological malignancy research and/or treatment and who have up to 3 years of postdoctoral research training (as of the award start date). Your Sponsor must have the appropriate experience to mentor you as you engage in blood cancer research.

Application Process:

The application process has three phases. The first phase is submission and consideration of eligibility. All eligible applicants will be invited to proceed to the Letter of Intent and Full Application phases. All submissions must be made through the LLS Research Portal.

Please visit the website for how to apply. Detailed instructions for each award category are found in the CDP Guidelines and Instructions. For questions, please contact researchprograms@lls.org.

The National Resource Center Award RFA was launched this month with an application deadline of November 13, 2024. National Resource Centers are supported by the CF Foundation to provide unique ‘Cores’ of expertise to the CF clinical research community, including centralized and core-specific services, training in specialized testing, consulting to investigators and sponsors, development of standard operating procedures and training for CF clinical research methodology, standardization of assays for multicenter clinical trials, and advancement of biomarkers and clinical endpoints relevant to CF For questions, please contact Elizabeth Yu (eyu@cff.org)

Funding of up to $175,000 per year, plus an additional twelve percent (12%) indirect costs may be requested. Awards may be approved for up to a five (5) year period. Funding for subsequent years is contingent upon submission and approval of a renewal progress report and the availability of funds. 

Career Development Award

Proposal deadline: Wednesday, December 5, 2024

Supports highly promising healthcare and academic professionals in the early years of first professional appointment to assure the applicant’s future success as a research scientist in the field of cardiovascular and/or cerebrovascular disease research.

Research Supplement to Promote Diversity in Science

Proposal deadline: Thursday, February 6, 2025

To enable current AHA awardees to identify and serve as mentors for predoctoral and postdoctoral fellows from underrepresented groups in science and medicine.

LOI due: November 4, 2024

Amount: $750,000 over three years

The MIND (Maximizing Innovation in Neuroscience Discovery) Prize supports and empowers early-to-midcareer investigators to rethink conventional paradigms around neurodegenerative diseases. Projects may range from the invention of novel tools, techniques, and technologies for mapping and analyzing the brain to bold approaches that demonstrate extraordinary therapeutic potential. Research domains may include—but are not limited to—neurobiology, brain imaging and mapping, machine learning, drug delivery, and synthetic biology. The foundation seeks high-risk, high-reward proposals that focus on novel interdisciplinary approaches to neuroscience research and are grounded in sound reasoning from first principles. The MIND Prize was created to fund projects that have been deemed too risky or speculative for traditional funding sources but still hold the potential for radical impact. Proposals that articulate a clear application to neurodegenerative and neurocognitive disorders, with a lens of Alzheimer’s Disease and Dementias, will be favored.

Eligibility: An MD, PhD, or MD-PhD (or equivalent) is required. Applicants must have completed at least one (1) but no more than ten years of independent research experience as a tenure-track faculty member by the start date of the Prize (May 2025). An applicant, who is not a U.S. citizen or permanent resident, by submitting an application for this funding, assures that his/her visa status will provide sufficient time to complete the project and grant term within the United States. Investigators need not be specifically trained in neuroscience.

Link: Pershing Square MIND Prize RFP

Contact: Audrey McInerney (amcinerney@montefiore.org) for information and/or assistance.

Due: December 1, 2024 (LOI)

Amount: Up to $300,000 over 3 years

Foundation supports “educational projects that improve health by advancing the

education and training of future health professionals.” Priority Areas include: Promoting diversity, equity, and belonging; Increasing collaboration among future health professionals, with an emphasis on developing exemplar teams; Preparing future health professionals to navigate ethical dilemmas.

Link: The Macy Foundation - Our Grantees

Contact: Audrey McInerney (amcinerney@montefiore.org) for information and/or assistance.

• Due: December 1, 2024 (LOI)

• Amount: $300,000/3 years

• CRI established CLIP to support investigators who are studying critical topics at

the intersection of laboratory and clinical research. They are seeking research projects that can be directly applied to optimizing cancer immunotherapy in the clinic. Must hold a faculty appointment as a tenure-track assistant professor or higher at time of award. CRI has no citizenship restrictions.

• Link: CLIP RFP

Contact: Audrey McInerney (amcinerney@montefiore.org) for information and/or assistance.

• Due: December 2, 2024 @ 4 pm

• Amount: $240,000/3 years

• Open to computational scientists with an interest in the intersection between quantitative biology, data science and cancer research. The purpose is to identify computational scientists who innovatively combine quantitative analyses and modeling to solve biological questions. This award encourages scientists, trained in fields such as mathematics, computer science, physics, or engineering to pursue research careers in computational biology and to bring their skills to bear on important questions in cancer biology.

Applicants must have two Mentors (one from dry lab and one from wet lab) and must not have been in their Mentors’ labs for more than 24 months prior to the application deadline. Preference will be given to mentorship teams where the labs are in close physical proximity to encourage frequent in person training. Must demonstrate the innovation of the computational methods. Physician-scientists must devote their principal time (at least 80 percent) to Damon Runyon-supported research activities. Activities constituting the remaining 20 percent of time should be clearly specified in the application and in the annual progress report.

Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO.



• Link: Damon Runyon Quantitative Biology Fellowship Award Overview

• Due: December 2, 2024 @ 4 pm

• Amount: $460,000/4 years

• Damon Runyon wishes to encourage more physicians to pursue research careers. To do

so, the Foundation established a program designed to recruit outstanding U.S. Specialty Board eligible physicians into cancer research careers by providing them with the opportunity for protected research training under the mentorship of a highly qualified and gifted mentor after they have completed all their clinical training. Must have a Mentor. Applicants (MDs and DOs only) must have completed residencies and clinical training, be U.S. Specialty Board eligible prior to the award start date, and be able to devote at least 80% time and effort to research.

MD/PhDs are not eligible to apply. Applicants cannot be pursuing a PhD. Applicants may apply at any time prior to their initial assistant professorship appointment (or equivalent). Postdoctoral fellows, clinical fellows, and clinical instructors are eligible to apply. Candidates holding or awarded NIH K awards at the time of application are not eligible to apply.



• Link: Damon Runyon Physician-Scientist Training Award

Contact: Audrey McInerney (amcinerney@montefiore.org) for information and/or assistance.

• LOI Due: December 3, 2024

• Amount: $1,150,000 over five years

• The award will support PIs who are outstanding early- to mid-career biomedical

researchers who—through their outreach, mentoring, teaching, and leadership—have a record of promoting diversity, equity, and inclusion in their scientific communities. They will have made significant research contributions to the biomedical sciences, show promise for continuing scientific achievement, and demonstrate leadership in efforts to diversify the sciences. The grant is to support the awardee’s research program with reasonable flexibility on how these funds are utilized, provided that funds are used to support the awardee’s overall academic program. Preference will be given to research programs that align with CZI Science and/or programs with diversity as a research component. Must hold an MD, PhD, ScD, MD/PhD, DDM, DVM, or equivalent degree and have a faculty position or equivalent independent investigator status. Non-tenured and tenured faculty are eligible to apply.

• Link: Science Diversity Leadership RFP

Contact: Audrey McInerney (amcinerney@montefiore.org) for information and/or assistance.

Due: December 4, 2024

• Amount: $300,000 over 3 years

• The intent of this award is to foster the scientific independence of junior investigators to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for research (i.e., a minimum of 50 percent effort dedicated to the proposed project). Applicants for this award must hold an MD, PhD and/or equivalent degree. Applicants may select clinical or basic/translational focus. Applicants are required to have a sponsor and mentor for the award

• Link: AGA Research Scholar Award (RSA) - American Gastroenterological Association

• Due: December 4, 2024

• Amount: $300,000 over 3 years

• To support early-career investigators working toward independent and productive

careers in pancreatic cancer research… Applicants performing any type of research (basic, translational or clinical) relevant to digestive disorders are eligible to apply.

• Link: AGA-Bern Schwartz Family Fund Research Scholar Award in Pancreatic Cancer (Fund A) - American Gastroenterological Association

Contact: Audrey McInerney (amcinerney@montefiore.org) for information and/or assistance.